Loerop James
SEC insider (Form 3/4/5 filer). CIK 0001781549. Chief Business Officer at Aclaris Therapeutics, Inc. (ACRS). 24 reported Form 4/5 transactions since Sep 2024; latest on Feb 3, 2026. Located in WAYNE, PA.
Companies Loerop James has filed insider reports for
- Aclaris Therapeutics, Inc. (ACRS): Officer, Chief Business Officer
Loerop James
CIK: 0001781549
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Aclaris Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (24 total)
- Feb 3, 2026ACRS
Aclaris Therapeutics, Inc.
ExerciseDirect20.9K shares- - Feb 3, 2026ACRS
Aclaris Therapeutics, Inc.
Tax PaymentDirect5.9K shares at avg. $3.47$21K - Feb 2, 2026ACRS
Aclaris Therapeutics, Inc.
AwardDirectEmployee Stock Option (Right to Buy)
341.9K shares- - Feb 2, 2026ACRS
Aclaris Therapeutics, Inc.
AwardDirectRestricted Stock Units
97.7K shares- - Feb 1, 2026ACRS
Aclaris Therapeutics, Inc.
ExerciseDirect11.3K shares- - Feb 1, 2026ACRS
Aclaris Therapeutics, Inc.
Tax PaymentDirect10.7K shares at avg. $3.51$38K - Feb 1, 2026ACRS
Aclaris Therapeutics, Inc.
ExerciseDirect14.8K shares- - Feb 1, 2026ACRS
Aclaris Therapeutics, Inc.
ExerciseDirect7.5K shares- - Jan 2, 2026ACRS
Aclaris Therapeutics, Inc.
ExerciseDirect18.2K shares- - Jan 2, 2026ACRS
Aclaris Therapeutics, Inc.
Tax PaymentDirect6.2K shares at avg. $2.88$18K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Feb 3, 2026 | ACRS Aclaris Therapeutics, Inc. | Exercise | 20,875 | - | $0 | Direct |
| Feb 3, 2026 | ACRS Aclaris Therapeutics, Inc. | Tax Payment | 5,937 | $3.47 | $20,601 | Direct |
| Feb 2, 2026 | ACRS Aclaris Therapeutics, Inc. | Award Employee Stock Option (Right to Buy) | 341,900 | - | - | Direct |
| Feb 2, 2026 | ACRS Aclaris Therapeutics, Inc. | Award Restricted Stock Units | 97,700 | - | - | Direct |
| Feb 1, 2026 | ACRS Aclaris Therapeutics, Inc. | Exercise | 11,250 | - | $0 | Direct |
| Feb 1, 2026 | ACRS Aclaris Therapeutics, Inc. | Tax Payment | 10,686 | $3.51 | $37,508 | Direct |
| Feb 1, 2026 | ACRS Aclaris Therapeutics, Inc. | Exercise | 14,750 | - | $0 | Direct |
| Feb 1, 2026 | ACRS Aclaris Therapeutics, Inc. | Exercise | 7,500 | - | $0 | Direct |
| Jan 2, 2026 | ACRS Aclaris Therapeutics, Inc. | Exercise | 18,150 | - | $0 | Direct |
| Jan 2, 2026 | ACRS Aclaris Therapeutics, Inc. | Tax Payment | 6,171 | $2.88 | $17,772 | Direct |
1-10 of 24 transactions